Protein Levels of Anti-Apoptotic Mcl-1 and the Deubiquitinase USP9x Are Cooperatively Upregulated during Prostate Cancer Progression and Limit Response of Prostate Cancer Cells to Radiotherapy
Background: Radiotherapy constitutes an important therapeutic option for prostate cancer. However, prostate cancer cells often acquire resistance during cancer progression, limiting the cytotoxic effects of radiotherapy. Among factors regulating sensitivity to radiotherapy are members of the Bcl-2 p...
Main Authors: | Sophia A. Hogh-Binder, Diana Klein, Frederik Wolfsperger, Stephan M. Huber, Jörg Hennenlotter, Arnulf Stenzl, Justine Rudner |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/9/2496 |
Similar Items
-
The Deubiquitinase USP13 Maintains Cancer Cell Stemness by Promoting FASN Stability in Small Cell Lung Cancer
by: Juhong Wang, et al.
Published: (2022-07-01) -
Immune Evasion and Drug Resistance Mediated by USP22 in Cancer: Novel Targets and Mechanisms
by: Jinhui Guo, et al.
Published: (2022-07-01) -
The downregulation of Mcl-1 via USP9X inhibition sensitizes solid tumors to Bcl-xl inhibition
by: Peddaboina Chander, et al.
Published: (2012-11-01) -
Role of ubiquitin specific proteases in the immune microenvironment of prostate cancer: A new direction
by: Jinhui Guo, et al.
Published: (2022-07-01) -
Deubiquitinase USP9x Confers Radioresistance through Stabilization of Mcl-1
by: Donatella Trivigno, et al.
Published: (2012-10-01)